Yield10 Bioscience Inc.’s recently made public that its 10% Owner SCHULER JACK W acquired Company’s shares for reported $1.0 million on May 05. In the deal valued at $2.98 per share,335,570 shares were bought. As a result of this transaction, SCHULER JACK W now holds 962,956 shares worth roughly $ 0.33 million.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Then, SCHULER JACK W sold 608 shares, generating $1,082 in total proceeds. Upon selling the shares at $1.78, the 10% Owner now owns 627,386 shares.
Before that, SCHULER JACK W sold 5,100 shares. Yield10 Bioscience Inc. shares valued at $8,976 were divested by the 10% Owner at a price of $1.76 per share. As a result of the transaction, SCHULER JACK W now holds 627,994 shares, worth roughly $0.21 million.
H.C. Wainwright initiated its Yield10 Bioscience Inc. [YTEN] rating to a Buy in a research note published on Friday, September 10, 2020; the price target was $25. PT values the company’s stock at a premium of 98.64 to its Friday closing price.
Price Performance Review of YTEN
On Friday, Yield10 Bioscience Inc. [NASDAQ:YTEN] saw its stock fall -5.04% to $0.34. On the same session, the stock had its day’s lowest price of $0.3131, but rose to a high of $0.3701. Over the last five days, the stock has lost -22.95%. Yield10 Bioscience Inc. shares have fallen nearly -79.69% since the year began. Nevertheless, the stocks have fallen -89.20% over the past one year. While a 52-week high of $4.19 was reached on 01/26/23, a 52-week low of $0.33 was recorded on 09/01/23. SMA at 50 days reached $1.4334, while 200 days put it at $2.4073. A total of 1.96 million shares were traded, compared to the trading of 0.98 million shares in the previous session.
Levels Of Support And Resistance For YTEN Stock
The 24-hour chart illustrates a support level at 0.3114, which if violated will result in even more drops to 0.2837. On the upside, there is a resistance level at 0.3684. A further resistance level may holdings at 0.3977. The Relative Strength Index (RSI) on the 14-day chart is 18.05, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0552, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.00%. Stochastics %K at 15.74% indicates the stock is a buying.
How much short interest is there in Yield10 Bioscience Inc.?
A steep rise in short interest was recorded in Yield10 Bioscience Inc. stocks on Aug 14, 2023, growing by 0.13 million shares to a total of 0.16 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 34990.0 shares. There was a rise of 78.3%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 1.49% of the overall stock float, the days-to-cover ratio (short ratio) rose to 0.3.
Yield10 Bioscience Inc. [YTEN] – Who Are The Largest Shareholders?
In filings from Cannell & Co., it is revealed that the company now owns 258,838 shares, or roughly 4.24% of the outstanding YTEN shares.. At present, Birchview Capital LP is holding 18,750 shares valued at $39000.0. Tower Research Capital LLC owned 4,915 shares of the company at the time of its most recent 13F filing, worth $10223.0.
According to FactSet, Yield10 Bioscience Inc.’s share price will average $2.83 in the next year, based on opinions of analysts polled by the firm. This is up nearly 733.33 percent from its previous closing price of $0.36. Analysts expect Yield10 Bioscience Inc. stock to reach the higher price of $4.00, while the lowest price estimate is $1.50. However, 3 analysts have rated YTEN stock as a Buy in their predictions for 2023.